Kocoglu MH, Richardson PG, Mo CC, Rapoport AP, Atanackovic D. Defibrotide improves COVID-19-related acute respiratory distress syndrome in myeloma patients after chimeric antigen receptor T-cell treatment without compromising virus-specific and anti-myeloma T-cell responses. Haematologica 2024;109(7):2372-2377; https://doi.org/10.3324/haematol.2023.284793.